Dr. House
Dr. House
Monday, June 20, 2016
Herpes Vaccine Cuts Shedding, Lesions Investigational drug GEN-003 promising in phase II trial
An investigational therapeutic vaccine sharply reduced the rate of viral shedding for a year in people with genital herpes (HSV2), a researcher said here. http://www.medpagetoday.com/MeetingCoverage/ASMMicrobe/58642?xid=nl_mpt_DHE_2016-06-20&eun=g721819d0r
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment